By Camillus Eboh ABUJA (Reuters) -Lassa fever killed 118 people in Nigeria in the first three months of this year, the West African country's Centre for Disease Control and Prevention (NCDC) said. The ...

The Nigeria Centre for Disease Control and Prevention has recorded 645 confirned Lassa fever cases out of 3,465 suspected cases from January to March, 2025, in 33 states, across 91 local government ...

After more than 20 years of research on arenaviruses, an Institut Pasteur team led by Sylvain Baize has developed an original vaccine platform known as MOPEVAC, which will strengthen the Institut ...

NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...

NIH-Sponsored Trial of Lassa Vaccine Opens - Viral Hemorrhagic Disease Can be Fatal & Causes Permanent Hearing Loss ...

A type of rodent called the multimammate rat carries the Lassa fever virus in its pee and poop. There are lots of these rats in West, Central, and East Africa. They tend to live in homes and in ...

An NIH-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants.

Lassa fever vaccine is one step closer to approval. Lassa virus infections, primarily spread by rodents, can cause a fatal ...

The Nigeria Centre for Disease Control and Prevention (NCDC) has intensified efforts to curb the spread of Lassa fever ...

The Nigeria Centre for Disease Control and Prevention (NCDC) has confirmed that 118 lives were lost to Lassa fever during the first quarter of 2025. This was disclosed in a statement on Sunday by the ...

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.